Table 3.
Predictor cut-off value | Events | PYFU | Sensitivity* | Specificity | Positive Predictive value | Hazard Ratio** (95% CI) | p-value | |
---|---|---|---|---|---|---|---|---|
CD4 cell count | ||||||||
<250 | 4 | 44.4 | 51.5 (14.1–91.7) | 82.8 (78.4–87.0) | 9.0 (2.5–23.1) | 4.7 (1.2–18.6) | 0.03 | |
<350 | 5 | 84.4 | 64.6 (24.6–100.0) | 64.7 (59.3–69.8) | 5.9 (1.9–13.8) | 3.3 (0.8–13.7) | 0.10 | |
CD4 cell count | IFN-γ | |||||||
≥250 | >0 | 3 | 137.5 | 78.0 | 33.4 (27.3–39.5) | 2.2 (0.4–6.4) | 1.5 (0.2–14.4) | 0.73 |
≥ 6 | 3 | 98.9 | 76.3 | 53.5(47.1–59.8) | 3.0 (0.6–8.9) | 3.3 (0.3–31.6) | 0.30 | |
≥ 10 | 2 | 85.4 | 47.5 | 59.2(53.3–65.2) | 2.3 (0.3–8.5) | 1.4 (0.2–10.1) | 0.72 | |
<250 | >0 | 3 | 21.7 | 84.6 | 47.7(33.8–61.4) | 13.8 (2.9–40.4) | 3.2 (0.3–30.7) | 0.32 |
≥ 6 | 3 | 15.6 | 89.4 | 63.3(50.4–78.4) | 19.2 (4.0–56.2) | 5.8 (0.6–55.9) | 0.13 | |
≥ 10 | 3 | 13.6 | 87.5 | 68.8(56.0–82.2) | 22.1 (4.5–64.5) | 7.0 (0.7–67.8) | 0.09 | |
≥350 | >0 | 2 | 113.7 | 74.5 | 30.3(24.1–36.2) | 1.8 (0.2–6.4) | 1.0 (0.1–10.6) | 0.97 |
≥ 6 | 2 | 81.1 | 73.8 | 51.0(44.0–58.2) | 2.5 (0.3–8.9) | 2.2 (0.2–23.8) | 0.53 | |
≥ 10 | 1 | 69.5 | 35.6 | 57.3(50.5–64.1) | 1.4 (0.04–8.0) | 0.7 (0.1–7.8) | 0.78 | |
<350 | >0 | 4 | 45.5 | 80.8 | 45.9(36.8–55.8) | 8.8 (2.4–22.5) | 3.4 (0.4–30.5) | 0.27 |
≥ 6 | 4 | 33.5 | 78.9 | 62.3(54.0–71.7) | 11.9 (3.3–30.6) | 6.0 (0.7–54.1) | 0.11 | |
≥ 10 | 4 | 29.4 | 79.4 | 67.0(57.6–75.7) | 13.6 (3.7–34.8) | 7.4 (0.8–66.1) | 0.07 |
Note: PYFU Person years of follow-up;
Confidence Intervals for sensitivity could not be calculated due to the very small number of events that the sensitivity estimate was based on.
Crude Hazard Ratio for active TB in women below CD4 cut-off value compared with women above CD4 cut-off value